Nikavir
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
23 patients were treated with the acute stage of
HIV infection for 8-48 weeks. All patients received
antiretroviral therapy with…
OBJECTIVES
The goal of this work was to study the immunological and virological efficacy of the domestic antiretroviral drug…
Federation Convincing evidence for high therapeutic activity and tolerability of Phosphazide in the treatment of HIV/AIDS…
The review sums up the results of using the antiretroviral drug phosphazide (Nikavir) as a component of HAART delivered to HIV…
In 2007-2008, the Perm Territorial Center for Prevention and Control of AIDS and Communicable Diseases investigated the efficacy…
: Nikavir (phosphazide) is an antiretroviral agent of the class of inhibitors of type 1 HIV reverse transcriptase. It was…
Nikavir (phosphazide) is an antiretroviral agent of the class of inhibitors of type 1 HIV reverse transcriptase. It was designed…
New antiviral drug "Nikavir" was clinically tested in acute hepatitis B (AHB). A total of 60 AHB patients were followed up; 30…
New antiviral drug "Nikavir" was clinically tested in acute hepatitis B (AHB). A total of 60 AHB patients were followed up; 30…